CRGC News Broadcast NB-2023-004
March 29, 2023

Follow this link to a listing of SEER SINQ's that have been finalized during the months of January and February 2023.

Highlights of this listing include:

  • 20220048 advises how to properly code treatment that is part of a clinical trial.

  • 20220043 informs how to correctly code Neoadjuvant Therapy for a melanoma diagnosed in the lymph nodes with no primary skin site identified.

  • 20220037 instructs how to code histology of a papillary epithelial tumor of the sella (PPETS).

Click here to access the SEER SINQ Website.
If you have questions or concerns regarding any of the content of this CRGC News Broadcast please contact me.

Mignon Dryden, CTR
Director, E-Reporting
Cancer Registry of Greater California